find a hospital about us contact us
       
our therapyhealthcare professionalspatientsnews/eventsclinical evidencesuccess stories resourcesmedia

Healthcare Professionals

Aquapheresis with the Aquadex FlexFlow was designed to be a powerful tool for healthcare professionals dealing with patients with fluid overload.

Distinguishing Features of the Aquadex FlexFlow:

  • simplicity of operation - only one required user setting
  • peripheral and central venous access options
  • can be quickly transported, setup, and operated in numerous clinical locations (inpatient and outpatient)
  • removes excess fluid ISOTONICALLY, therefore, removes the greatest possible amount of sodium per unit of fluid withdrawn
  • clinically shown to reduce length of stay and readmissions compared to standard diuretic care

Frequently Asked Questions

Q: What does it do?
A: Removes excess salt and water from patients with fluid overload by filtering blood withdrawn from and returned to a patient's veins.

The Aquadex FlexFlow is highly automated and has only one required setting, the rate that you want the fluid to be removed - settable from 0 to 500 mL/hr in increments of 10. This is the rate at which the excess fluid will be pulled off and how quickly the collection bag will fill. The average is 250 mL/hr.

One can think of the Aquadex FlexFlow as a mechanical diuretic. But unlike diureric drugs, the Aquadex FlexFlow can remove the excess fluid in a controllable and predictable fashion.

For more details, go to "Aquapheresis and How It Works".


Q: How does it do it?
A: It uses a technique in which blood containing excess fluid is withdrawn and passed through a special filter (hemofilter). The filter removes the excess fluid from a patient's blood. The filtered blood is returned to the patient and the removed fluid is collected in a bag for later disposal.

The Aquadex FlexFlow filter uses a simple pressure difference (i.e. higher pressure inside vs. lower pressure outside) to selectively push elements in the blood through tiny holes (pores) in the walls of the numerous filter fibers. This is referred to as convective transport (because it uses only pressure and size).

It is the walls of these fibers that make up the filter membrane and it is through their tiny embedded pores that the excess fluid from the blood passes. Literally, only appropriately sized elements of the blood fit through the filter's pores and are removed, all others remain in the blood and are returned to the patient.

Only a small pressure difference is used to drive this size-based separation process. No other chemical forces or concentration gradients are created by the Aquadex FlexFlow that could cause an electrolyte imbalance. That is, because the removed fluid on the other side of the filter is in chemical equilibrium with the blood, no diffusive transport occurs, only convective transport and that's why the fluid removed is always ISOTONIC to blood.

 

For more details, go to "Aquapheresis and How It Works".

Q: What are the specifications of your filter?
A: The filter is made up of hundreds of hollow fiber tubes of polysulfone membrane material with the following properties:

Filter Mechanical Properties:

Surface area (approx.): 0.12 square meters
Max Removal Rate: 500 mL/hr
Blood Volume (approx.): 7 mL

UF 500 Set Blood Volume (approx.):       

33 mL
Access port priming volume (approx.):       2 mL

Filter Coefficients*: (37±1°C, blood flow rate 40 mL/min., UFR 8.3 mL/min.)

Urea Sieving (saline) 0.98
Creatinine Sieving (saline) 0.98
Vitamin B12 Sieving (saline) 0.98
Albumin Sieving, 65,000 MW Daltons (**) <0.02
Ultrafiltration (**) 5.6 mL/hr/mmHg

Transmembrane Pressure, TMP (**)
at a UF rate of 500 ml/hr.

100 mmHg

* Typical values obtained from laboratory testing of post-sterilization lots. Results may vary based on clinical and patient conditions.
** bovine blood, albumin concentration 6 ±0.2 g/dl

Performance specifications of a similar polysulfone membrane in a 1.25 square meter device:

Sieving coefficients***:

B12 1,355 MW-Daltons .96
Inulin 5,000 MW-Daltons .79
Cytochrome-C 12,384 MW - Daltons .50
Myoglobin 17,000 MW-Daltons .50
Albumin 65,000 MW-Daltons <.001

*** bovine blood, blood flow @ 200 mL/min,TMP @ 100 mmHg and plasma protein level = 5.0 g/dl

Q: On whom can I use it? / What's its indication for use?
A: The Aquadex FlexFlow removes fluid only. It is targeted for patients with fluid overload who have failed diuretic therapy and not for those with End Stage Renal Disease (ESRD) or chronic renal failure. If a patient needs dialysis, they should be on dialysis.

For more details, go to "Aquapheresis Prescription".

Q: What's different about the Aquadex FlexFlow and other hemofiltration/hemodialysis/CVVH machines?

A:
1.
No clinically significant impact on electrolyte balance, blood pressure or heart rate.
 
2.
Can be used in numerous and diverse settings (inpatient or outpatient) - ICU/CCU/MICU, telemetry, stepdown, observation, ER, etc.
 
3.
Uses peripheral venous access for withdrawal and return of venous blood.
 
4.
Small, transportable, and easy to set up - circuit loading and priming takes 10 minutes, can operate on AC power or battery (up to 30 minutes).
 
5.
Highly automated operation, only one setting, and autonomously and intelligently attempts to maintain and reestablish blood flow without stopping and alarming.
 
6.
Designed for operation with floor and general medical practitioners in mind.
 
7.
Blood circuit designed to minimize clotting and the need for anticoagulation. From the tips of the catheters, through our connectors and filter, and back into the patient, the Aquadex FlexFlow's blood circuit was optimally designed to keep the blood flowing and the path from clotting.
 
8.
Minimal chance of hypotension. Blood flow is 10-40 mL/min and the total filter set volume is 33 mL. This is combined with the Aquadex FlexFlow's ability to precisely control the rate of removal to match the rate of fluid becoming available in the patient.

Q: Can I use it with central access?
A: Aquadex FlexFlow can be used with central or peripheral venous access. Venous access site and catherter choosen are based on what is the best for each individual patient and the total treatment plan for that patient.

For more details, go to "Aquapheresis Prescription".

Q: You claim to not significantly affect electrolyte balance/blood chemistry Explain how this works?
A: We do not use replacement fluid and filtration is based solely on size (blood cells, proteins, etc. cannot fit through the filter's pores) and uses only the slightly higher pressure on the inside of the fibers than on the outside (transmembrane pressure) to selectively push across the membrane (convection). The filter does not create any other gradients or forces to selectively extract out particular electrolytes.

Therefore, since the electrolytes can move freely across the filter membrane, they equalize. The levels of electrolytes in the blood are the same as that in the extracted fluid. It's ISOTONIC.

The fluid removed is made up of water, electrolytes and "small and medium molecules". Some of those are important, but there are large stores of these in the fluid overloaded patient. Since the fluid removed has the same electrolyte concentrations as those in the blood, their overall concentrations in the patient are not changed over the course of therapy. Therefore, the therapy neither improves nor worsens electrolyte balance, it keeps it constant.

Q: How long can we leave the catheters in a patient?
A: Depends on national and local institutional standard practice of care for peripheral and midline venous access and the fluid removal treatment plan worked out for each patient.

Q: Dialysis is an inflammatory stimulus, inducing cytokine production and complement activation. Don't you use the same filter material. Is this a problem?
A: Aquapheresis Therapy with the Aquadex FlexFlow is not dialysis. It is short term and not performed 3-4 times each week for up to 12 hours each time. Aquadex FlexFlow patients should not have End Stage Renal Disease (ESRD) or chronic renal failure and should have functional kidneys that may be acutely compromised due to the heavy fluid overload. Their kidneys can still process, filter, and reduce the effects of this complex process. Patients with ESRD or chronic renal failure cannot.

The Aquadex FlexFlow removes fluid only. If your patient needs dialysis, they should be on dialysis.

 

Clinical Evidence

Case Studies

Aquapheresis Prescription

Volume Calculator

Aquapheresis and How It Works

Aquapheresis Frequently Asked Questions

Training and Certification Program

Download Aquadex FlexFlow Brochure (PDF)

Forward This Page

Print This Page

 
 
  © 2008 chf solutions, Inc. | terms of use | privacy policy
home | contact